Monosaccharide Transport through Lipid Bilayers
J. Am. Chem. Soc., Vol. 118, No. 45, 1996 11099
prepared by standard literature procedures where the appropriate bromo
precursor was treated with butyllithium followed by trimethyl borate.
Liposome Transport Assays. (A) Glucose Efflux. The rate of
glucose efflux was determined by the method of Kinsky.31 Aliquots
of the above liposome preparation (usually 40 µL, final concentration
of phospholipid plus cholesterol was 0.75 mM) encapsulating 300 mM
of glucose were added to two 1 mL cuvettes. One cuvette contained
the complete assay solution of 35 mM sodium phosphate, pH 7.5, 75
mM NaCl, 2 mM MgCl2, 2.5 units of enzyme (hexokinase/glucose-6-
phosphate dehydrogenase), 1 mM ATP, and 0.5 mM NADP. The other
cuvette contained the same reagents except for the NADP and was a
control solution used to correct for background absorption at 340 nm.
The boronic acids were added as small aliquots of concentrated aqueous
or DMSO solutions (the final concentration of DMSO was almost
always less than 5%), and the absorbance at 340 nm was monitored
over time. The initial efflux rates were determined from the amount
of glucose transported after the first 10 min. There was no glucose
consumption if the glucose was inside the liposomes and boronic acids
were absent, proving that the enzymes were unable to penetrate the
liposomes. Facilitated efflux generally occurred over a period of hours,
whereas enzyme turnover rates were much faster.31 If the glucose was
not encapsulated within the liposome, then it was totally consumed by
the coupled enyzme system within 1 min. The total amount of glucose
encapsulated inside the liposomes was determined by lysing the
liposomes with 100 µL of 10% Triton-X-100 solution at the end of
each assay.
(B) Glucose-6-phosphate Efflux. The procedure was the same as
that for glucose efflux except the liposomes were prepared with 300
mM glucose-6-phosphate as the encapsulated marker compound, and
ATP and hexokinase were deleted from the assay.
(C) Fructose Efflux. The procedure was the same as that for
glucose efflux except the liposomes were prepared with 300 mM
fructose as the encapsulated marker compound and the enzyme
phosphoglucoisomerase (5.0 units/mL) was added to the mixed enzyme
system.32
(D) Fructose-6-phosphate Efflux. The procedure was the same
as that for glucose efflux, except the liposomes were prepared with
300 mM fructose-6-phosphate as the encapsulated marker compound
and the enzyme phosphoglucoisomerase (5.0 units/mL) was added to
the mixed enzyme system, while ATP and hexokinase were deleted.
(E) Sorbitol Efflux. The procedure was similar to that for glucose
efflux, except the liposomes were prepared with 300 mM sorbitol as
the encapsulated marker compound and the enzyme was sorbitol
dehydrogenase (2 units/mL).
(A) Ester Boronic Acids 18-20. These compounds were prepared
by alkylating (4-carboxyphenyl)boronic acid (8) using the following
general procedure. Potassium hydrogen carbonate (2 mmol) was added
to a solution of 8 (0.6 mmol) in DMF (30 mL). The mixture was
stirred at reflux for 2 h. The appropriate alkylating agent (dimethyl
sulfate, benzyl bromide, or 4-tert-butylbenzyl bromide, 0.7 mmol) was
added, and the mixture was heated overnight at 60 °C. After standard
workup, the crude product was purified by column chromatography.
For 18: 1H NMR (CD3COCD3 plus 1 drop of D2O) 3.87 (s, 3H), 7.96
(s, 4H) ppm; 13C NMR (CD3COCD3 plus 1 drop of D2O) 52.3, 116.0,
129.0, 132.3, 135.0, 167.5 ppm; HRMS (positive FAB with glycerol
matrix) [M + 57]+ ) 237.0934, calcd for M ) C8H9BO4 237.0936.
For 19: 1H NMR (CD3COCD3) 5.37 (s, 2H), 7.32-7.51 (m, 5H), 7.97
(d, 2H), 8.02 (d, 2H) ppm; HRMS (positive FAB with glycerol matrix)
[M + 57]+ ) 313.1284, calcd for M ) C14H13O4B 313.1262. For 20:
1H NMR (CD3COCD3) 1.29 (s, 9H), 5.32 (s, 2H), 7.42 (s 4H), 7.97 (s,
4H). Due to extensive fragmentation, HRMS could not be performed.
(B) 3-(N-Methylnicotinamidophenyl)boronic Acid (21). Nicotinic
acid (1.82 mmol) and (3-aminophenyl)boronic acid (1.82 mmol) were
coupled together using N,N′-carbodiimidazole (1.82 mmol) in THF. A
standard workup produced 3-(nicotinamidophenyl)boronic acid as a
white solid (yield 49%): 1H NMR (CD3SOCD3 plus 1 drop of D2O)
7.33 (t, 1H), 7.54 (m, 2H), 7.79 (d, 1H), 8.00 (s, 1H), 8.27 (d, 1H),
8.72 (d, 1H), 9.06 (s, 1H) ppm; 13C NMR (CD3COCD3 plus 1 drop of
D2O) 123.4, 124.5, 126.9, 128.6, 129.3, 130.9, 131.6, 136.4, 138.4,
148.9, 152.4, 165.1 ppm; HRMS (positive FAB with glycerol matrix)
[M + 57]+ ) 299.1213, calcd for M ) C15H16N2BO4 299.1206. A
solution of 3-(nicotinamidophenyl)boronic acid (0.33 mmol) in acetone
was treated with iodomethane (1.0 mmol). After 3 h a precipitate had
formed, which was filtered to give 21 as its iodide salt (yield 25%):
1H NMR (CD3COCD3) 4.43 (s, 3H), 7.39 (t, 1H), 7.63 (d, 1H), 7.88
(d, 1H), 8.01 (s, 1H), 8.12 (s, 1H), 8.29 (t, 1H), 9.02 (d, 1H), 9.13 (d,
1H), 9.51 (s, 1H) ppm; 13C NMR (CD3COCD3 plus 1 drop of D2O)
49.4, 133.5, 136.9, 137.9, 139.1, 141.6, 147.7, 154.3, 154.5, 155.9,
158.0, 171.7 ppm; HRMS (positive FAB with glycerol matrix) [M +
56]+ ) 313.183, calcd for M ) C16H19N2BO4 313.1363.
Liposome Preparation.16 A chloroform solution of dipalmit-
oylphosphatidylcholine (DPPC, 2 µmol), cholesterol (C, 1.5 µmol), and
egg phosphatidic acid (PA, 0.2 µmol) was evaporated using a rotary
evaporator (<30 °C), and the lipid film was dried under vacuum for 1
h (longer drying times had no apparent effect on observed transport
results). The liposomes were dispersed in 200 µL of marker solution
(depending on the purpose of the experiment, the solution was either
water or 35 mM sodium phosphate buffer with 75 mM NaCl at pH
7.5) with the aid of a Vortex mixer. Pyrex beads were added before
vortexing to facilitate removal of the lipid film from the sides of the
flask. The resulting opaque dispersion was frozen in an ethanol/dry-
ice bath and then allowed to thaw in a water-bath at 37 °C. This
freeze-thaw cycle was repeated 10 times. The resulting mixture was
extruded, at room temperature, 29 times through a 19 mm polycarbonate
filter (Nucleopore) with 100 nm diameter pores using a hand-held Basic
LiposoFast device purchased from Avestin, Inc., Ottawa, Canada.17 The
extrusion device consisted of a machined housing that secured the
polycarbonate filter between two 0.5 mL syringes. The liposomal
mixture was forced back and forth from one syringe to the other. An
odd number of passages ensured that the mixture always ended up in
the receiving syringe. This method has been shown to produce LUVs
with a mean diameter of 80 nm.17 To separate untrapped marker
compound, the mixture was dialyzed against NaCl solution (0.15 M)
for at least 2 h using dialysis tubing of 15 000 MW cut-off. Ocas-
sionally, Sephadex G-50 minispun columns were used to rapidly
separate untrapped marker from the liposomes.16 The amount of
phospholipid in the liposomal fraction after separation was determined
using the Stewart assay and the amount of encapsulated glucose by
the enzymatic assay decribed below.16 The encapsulation volume was
typically around 1.0 µL/µmol of lipid.
(F) Sucrose Efflux. The procedure was the same as that for fructose
efflux except the liposomes were prepared with 300 M sucrose as the
encapsulated marker compound and invertase (1.0 units/mL) was added.
Note that 2 equiv of NADPH are produced for each equivalent of
sucrose consumed.
(G) Isocitrate Efflux. The procedure was the same as that for
glucose efflux except the liposomes were prepared with 300 mM
isocitrate as the encapsulated marker compound, the assay enzyme was
isocitrate dehydrogenase (1.5 units/mL), and the ATP was deleted.33
(H) Arsenazo III Efflux. Liposomes were prepared with 3 mM
arsenazo III as the encapsulated marker compound. The assay utilizes
the 560 nm to 606/660 nm spectral shift of arsenazo III that occurs
when the dye binds calcium ions. Both the normal assay with arsenazo
inside and calcium outside the liposomes, as well as the reverse assay
with arsenazo and calcium inside and EDTA outside, were performed.
The literature method was followed, which monitored the change in
absorbance at 660 nm.16
(I) Carboxyfluoroscein/Calcein Efflux.16 Liposomes were prepared
with carboxyfluoroscein (CF, 100 mM in 10 mM sodium phosphate
buffer, pH 7.7) and glucose (300 mM) as the encapsulated marker
compounds. CF fluorescence is linearly proportional to concentration
between 3 and 30 µM. Above 30 µM self-quenching becomes
dominant. To monitor CF efflux, an aliquot of the liposome preparation
(40 µL) was added to a glass fluorescence cuvette containing 1 mL of
(31) Kinsky, S. C. In Methods in Enzymology; Fleischer, S., Packer, L.,
Eds.; Academic Press: London, 1974; Vol. 32, p 501-512.
(32) Beutler, H.-O. In Methods of Enzymatic Analysis, 3rd ed.; Berg-
meyer, H. U., Ed.; Verlag: Weinheim, 1983; Vol. 6, pp 321-327.
(33) Crowe, L. M.; Womersley, C.; Crowe, J. H.; Reid, D.; Appel, L.;
Rudolph, A. Biochim. Biophys. Acta 1986, 861, 131-140.